Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

NCT00338650 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott